Guangdong VTR Bio-Tech Co., Ltd.

Shenzhen Stock Exchange 300381.SZ

Guangdong VTR Bio-Tech Co., Ltd. Capital Expenditure for the year ending December 31, 2023: USD -55.52 M

Guangdong VTR Bio-Tech Co., Ltd. Capital Expenditure is USD -55.52 M for the year ending December 31, 2023, a -93.71% change year over year. Capital expenditure is cash spent on acquiring or maintaining fixed assets, such as property, plants, and equipment (PP&E).
  • Guangdong VTR Bio-Tech Co., Ltd. Capital Expenditure for the year ending December 31, 2022 was USD -28.66 M, a -11.74% change year over year.
  • Guangdong VTR Bio-Tech Co., Ltd. Capital Expenditure for the year ending December 31, 2021 was USD -25.65 M, a 40.85% change year over year.
  • Guangdong VTR Bio-Tech Co., Ltd. Capital Expenditure for the year ending December 31, 2020 was USD -43.36 M, a 24.11% change year over year.
  • Guangdong VTR Bio-Tech Co., Ltd. Capital Expenditure for the year ending December 31, 2019 was USD -57.14 M, a -26.32% change year over year.
Key data
Date Capital Expenditure Free Cash Flow Depreciation And Amortization Deferred Income Tax
Market news
SV Wall Street
Shenzhen Stock Exchange: 300381.SZ

Guangdong VTR Bio-Tech Co., Ltd.

CEO Mr. Derong Zhou
IPO Date Jan. 28, 2014
Location China
Headquarters No. 8 Pingbei Road 1
Employees 1,119
Sector Healthcare
Industries
Biotechnology Agriculture Biofuel Fertilizers Personal Care Pet Food Pharmaceuticals Plastics
Description

Guangdong VTR Bio-Tech Co., Ltd., focuses on research, development, and industrial application of bio-medicine, bio-agriculture, and animal husbandry. The company provides feed enzymes, functional feed additives, and industrial enzyme products. The company sells its products in approximately 60 countries and regions. Guangdong VTR Bio-Tech Co., Ltd. was founded in 1991 and is headquartered in Zhuhai, China.

StockViz Staff

February 3, 2025

Any question? Send us an email